vs
ARTIVION, INC.（AORT）とGIBRALTAR INDUSTRIES, INC.（ROCK）の財務データ比較。上の社名をクリックして会社を切り替えられます
GIBRALTAR INDUSTRIES, INC.の直近四半期売上が大きい（$225.0M vs $116.0M、ARTIVION, INC.の約1.9倍）。GIBRALTAR INDUSTRIES, INC.の前年同期比売上増加率が高い（24.9% vs 19.2%）。GIBRALTAR INDUSTRIES, INC.の直近四半期フリーキャッシュフローが多い（$26.2M vs $-7.9M）。過去8四半期でARTIVION, INC.の売上複合成長率が高い（9.1% vs -12.3%）
Artivion, Inc.は心血管移植向けの極低温保存した人体組織の流通、及び医療機器の開発を行う医療企業です。同社の製品には、余分な細胞物質と抗原を除去する処理を施した人間の心臓弁、手術用接着剤BioGlueなどがあり、臨床現場のニーズに応えています。
ジブラルタル・インダストリーズ社は、特殊建築資材、インフラ関連製品、再生可能エネルギー向け製品の製造・販売を行う有力企業です。換気システム、屋根用付属品、太陽光発電設置架台、造園用品などを取り扱い、主に北米の住宅・商業建設、クリーンエネルギー市場向けにサービスを提供しています。
AORT vs ROCK — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $116.0M | $225.0M |
| 純利益 | $2.4M | — |
| 粗利率 | 63.1% | 25.3% |
| 営業利益率 | 9.2% | 7.9% |
| 純利益率 | 2.1% | — |
| 売上前年比 | 19.2% | 24.9% |
| 純利益前年比 | 114.7% | — |
| EPS（希薄化後） | $0.06 | — |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $116.0M | $225.0M | ||
| Q3 25 | $113.4M | $310.9M | ||
| Q2 25 | $113.0M | $309.5M | ||
| Q1 25 | $99.0M | $290.0M | ||
| Q4 24 | $97.3M | $180.1M | ||
| Q3 24 | $95.8M | $277.1M | ||
| Q2 24 | $98.0M | $273.6M | ||
| Q1 24 | $97.4M | $292.5M |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $6.5M | $-89.1M | ||
| Q2 25 | $1.3M | $26.0M | ||
| Q1 25 | $-505.0K | $21.1M | ||
| Q4 24 | $-16.5M | — | ||
| Q3 24 | $-2.3M | $34.0M | ||
| Q2 24 | $-2.1M | $32.2M | ||
| Q1 24 | $7.5M | $24.9M |
| Q4 25 | 63.1% | 25.3% | ||
| Q3 25 | 65.6% | 26.6% | ||
| Q2 25 | 64.7% | 28.4% | ||
| Q1 25 | 64.2% | 26.8% | ||
| Q4 24 | 63.2% | 29.0% | ||
| Q3 24 | 63.7% | 29.4% | ||
| Q2 24 | 64.6% | 30.5% | ||
| Q1 24 | 64.6% | 28.9% |
| Q4 25 | 9.2% | 7.9% | ||
| Q3 25 | 11.1% | 12.8% | ||
| Q2 25 | 7.4% | 12.8% | ||
| Q1 25 | 2.2% | 8.8% | ||
| Q4 24 | 2.7% | 13.3% | ||
| Q3 24 | 4.6% | 15.6% | ||
| Q2 24 | 6.6% | 14.9% | ||
| Q1 24 | 26.0% | 10.8% |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 5.7% | -28.6% | ||
| Q2 25 | 1.2% | 8.4% | ||
| Q1 25 | -0.5% | 7.3% | ||
| Q4 24 | -16.9% | — | ||
| Q3 24 | -2.4% | 12.3% | ||
| Q2 24 | -2.2% | 11.8% | ||
| Q1 24 | 7.7% | 8.5% |
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.13 | $-2.98 | ||
| Q2 25 | $0.03 | $0.87 | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.05 | $1.11 | ||
| Q2 24 | $-0.05 | $1.05 | ||
| Q1 24 | $0.18 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $64.9M | $115.7M |
| 総負債低いほど良い | $215.1M | $0 |
| 株主資本純資産 | $448.2M | $950.4M |
| 総資産 | $884.8M | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.48× | 0.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $64.9M | $115.7M | ||
| Q3 25 | $73.4M | $89.4M | ||
| Q2 25 | $53.5M | $43.3M | ||
| Q1 25 | $37.7M | $25.1M | ||
| Q4 24 | $53.5M | $269.5M | ||
| Q3 24 | $56.2M | $228.9M | ||
| Q2 24 | $55.0M | $179.1M | ||
| Q1 24 | $51.1M | $146.7M |
| Q4 25 | $215.1M | $0 | ||
| Q3 25 | $214.9M | $0 | ||
| Q2 25 | $215.6M | $0 | ||
| Q1 25 | $314.7M | $0 | ||
| Q4 24 | $314.3M | $0 | ||
| Q3 24 | $314.0M | $0 | ||
| Q2 24 | $313.6M | $0 | ||
| Q1 24 | $313.3M | $0 |
| Q4 25 | $448.2M | $950.4M | ||
| Q3 25 | $438.7M | $951.8M | ||
| Q2 25 | $419.9M | $1.0B | ||
| Q1 25 | $294.3M | $1.0B | ||
| Q4 24 | $276.2M | $1.0B | ||
| Q3 24 | $304.7M | $1.0B | ||
| Q2 24 | $295.1M | $975.7M | ||
| Q1 24 | $295.0M | $940.2M |
| Q4 25 | $884.8M | $1.4B | ||
| Q3 25 | $857.7M | $1.4B | ||
| Q2 25 | $838.4M | $1.5B | ||
| Q1 25 | $791.2M | $1.4B | ||
| Q4 24 | $789.1M | $1.4B | ||
| Q3 24 | $803.1M | $1.4B | ||
| Q2 24 | $789.5M | $1.4B | ||
| Q1 24 | $784.0M | $1.3B |
| Q4 25 | 0.48× | 0.00× | ||
| Q3 25 | 0.49× | 0.00× | ||
| Q2 25 | 0.51× | 0.00× | ||
| Q1 25 | 1.07× | 0.00× | ||
| Q4 24 | 1.14× | 0.00× | ||
| Q3 24 | 1.03× | 0.00× | ||
| Q2 24 | 1.06× | 0.00× | ||
| Q1 24 | 1.06× | 0.00× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $19.6M | $35.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $-7.9M | $26.2M |
| FCFマージンFCF / 売上 | -6.9% | 11.7% |
| 設備投資強度設備投資 / 売上 | 23.7% | 4.1% |
| キャッシュ転換率営業CF / 純利益 | 8.06× | — |
| 直近12ヶ月FCF直近4四半期 | $839.0K | $120.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $19.6M | $35.5M | ||
| Q3 25 | $22.3M | $73.0M | ||
| Q2 25 | $15.0M | $44.9M | ||
| Q1 25 | $-17.0M | $13.7M | ||
| Q4 24 | $10.1M | $19.9M | ||
| Q3 24 | $11.5M | $64.7M | ||
| Q2 24 | $6.1M | $36.5M | ||
| Q1 24 | $-5.5M | $53.2M |
| Q4 25 | $-7.9M | $26.2M | ||
| Q3 25 | $17.7M | $64.8M | ||
| Q2 25 | $11.7M | $27.3M | ||
| Q1 25 | $-20.6M | $2.3M | ||
| Q4 24 | $8.7M | $14.1M | ||
| Q3 24 | $7.8M | $60.5M | ||
| Q2 24 | $3.6M | $33.5M | ||
| Q1 24 | $-9.1M | $48.8M |
| Q4 25 | -6.9% | 11.7% | ||
| Q3 25 | 15.6% | 20.8% | ||
| Q2 25 | 10.4% | 8.8% | ||
| Q1 25 | -20.8% | 0.8% | ||
| Q4 24 | 9.0% | 7.8% | ||
| Q3 24 | 8.2% | 21.8% | ||
| Q2 24 | 3.7% | 12.2% | ||
| Q1 24 | -9.3% | 16.7% |
| Q4 25 | 23.7% | 4.1% | ||
| Q3 25 | 4.1% | 2.6% | ||
| Q2 25 | 2.9% | 5.7% | ||
| Q1 25 | 3.7% | 3.9% | ||
| Q4 24 | 1.5% | 3.3% | ||
| Q3 24 | 3.8% | 1.5% | ||
| Q2 24 | 2.6% | 1.1% | ||
| Q1 24 | 3.7% | 1.5% |
| Q4 25 | 8.06× | — | ||
| Q3 25 | 3.42× | — | ||
| Q2 25 | 11.16× | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | -0.73× | 2.13× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AORT
| Aortic Stent Grafts | $43.3M | 37% |
| On X | $27.8M | 24% |
| Preservation Services | $24.1M | 21% |
| Surgical Sealants | $20.3M | 18% |
| Other Products | $463.0K | 0% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
